CClinicalTrials.gg
TerminatedNCT03141996NEGLECTUpdated Nov 30, 2018

Use of Vibration to Improve Visual/Spatial Neglect in Patients Affected by Stroke

An interventional study of Vibration to upper posterior neck muscles and Standard of Care in Unilateral Spatial Neglect, sponsored by Intermountain Health Care, Inc.. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-30.

Sponsored by Intermountain Health Care, Inc. · Not applicable, Interventional, and Supportive care

Why this study was terminated
Poor enrollment
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will measure if five minutes of vibration to the upper back neck muscles, prior to standard of care treatment, will improve symptoms of spatial neglect and/or activities of daily living function for patients who have had a stroke.

Read the detailed description

Spatial neglect is a common syndrome following stroke, most frequently of the right side of the brain. Such patients fail to be aware of objects or people to their left. This study is being done to learn if vibration treatment can improve visual/spatial neglect and activities of daily living in stroke patients better than current standard intervention.This treatment will be performed by occupational therapist practitioners prior to regular occupational therapy session using a vibration tool.

02

Conditions studied

  • Unilateral Spatial Neglect

Browse trials for

Keywords

  • vibration
  • stroke
  • activities of daily living
03

In context

Perceptual Disorders

92 studies on the registry are indexed under Perceptual Disorders; 23 are open to participants now.

This study's enrollment of 9 is below the median of 30 across 69 interventional studies indexed under Perceptual Disorders.

Browse Perceptual Disorders studies →

Lead sponsor

Intermountain Health Care, Inc. is the lead sponsor of 118 studies on the registry; 15 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 3 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years old or older
  • demonstrated visual/spatial neglect, as demonstrated by NIH Stroke Scale (NIHSS) and deficits in assessing tactile extinction and visuospatial neglect done on admission.

Exclusion criteria

Exclusion Criteria:

  • severe pain or skin disease at the posterior neck
  • severe atherosclerosis of carotid arteries by an ultrasonic evaluation
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Vibration to upper posterior neck muscles

    Treatment will be performed by occupational therapist practitioners prior to regular occupational therapy session using a vibration tool.

    Other: Vibration to upper posterior neck muscles

  • Active comparator
    Standard of care

    Regular occupational therapy session

    Other: Standard of Care

Interventions

  • OtherVibration to upper posterior neck muscles

    Vibration to upper posterior neck muscles using a vibrational tool.

    Also known as: Magic Wand Massager

  • OtherStandard of Care

    Standard of care treatment

06

What researchers measure

Primary outcomes

  1. Behavioral Inattention test

    A short screening battery of tests to assess the presence and the extent of visual neglect on a sample of everyday problems faced by patients

    Time frame: Day 0

Secondary outcomes

  1. Behavioral Inattention test

    A short screening battery of tests to assess the presence and the extent of visual neglect on a sample of everyday problems faced by patients

    Time frame: Day 30

  2. Behavioral Inattention test

    A short screening battery of tests to assess the presence and the extent of visual neglect on a sample of everyday problems faced by patients

    Time frame: Day 60

  3. Catherine Bergego Scale (CBS)

    a standardized checklist to detect presence and degree of unilateral neglect during observation of everyday life situations.

    Time frame: Day 0

  4. Catherine Bergego Scale (CBS)

    a standardized checklist to detect presence and degree of unilateral neglect during observation of everyday life situations.

    Time frame: Day 30

  5. Catherine Bergego Scale (CBS)

    a standardized checklist to detect presence and degree of unilateral neglect during observation of everyday life situations.

    Time frame: Day 90

  6. Activity Measure for Post-Acute Care (AM-PAC)

    AM-PAC measures patients' capabilities in functional areas for prioritization of therapy resources.

    Time frame: Day 0

  7. Activity Measure for Post-Acute Care (AM-PAC)

    AM-PAC measures patients' capabilities in functional areas for prioritization of therapy resources.

    Time frame: Day 30

  8. Activity Measure for Post-Acute Care (AM-PAC)

    AM-PAC measures patients' capabilities in functional areas for prioritization of therapy resources.

    Time frame: Day 60

07

Study locations

1 site
  • Intermountain Medical Center
    Murray, Utah 84157, United States
08

References and documents

Publications

  • Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4. PubMed 34196963 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 30, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03141996
Lead sponsor
Intermountain Health Care, Inc.
Responsible party
Sponsor
First posted
May 5, 2017
Start date
Apr 16, 2017
Primary completion
Apr 12, 2018
Completion
Apr 12, 2018
Last update
Nov 30, 2018

Study contacts

Florentina Mueller-Planitz
principal investigator · Intermountain Health Care, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion